PHAGEFINITY
DEAD

Serial Number

97108305

Owner

Adaptive Phage Therapeutics, Inc.

Attorney

Leesa N. Weiss

Filing Date

Nov 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PHAGEFINITY Trademark

Serial Number: 97108305

PHAGEFINITY is a trademark filed by Adaptive Phage Therapeutics, Inc. on November 4, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 11 (Environmental Control), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Adaptive Phage Therapeutics, Inc. (25 trademarks)

Gaithersburg, MD 20878

Entity Type: 03

Trademark Details

Filing Date

November 4, 2021

Registration Date

Not Registered

Published for Opposition

August 30, 2022

Goods & Services

custom manufacture of pharmaceuticals in the nature of bacteriophage therapeutics for others

Computer software system comprised of downloadable computer software for identifying precision therapy for treatment of bacterial infections

human, animal, plant and microorganism biological preparations for disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the field of medicine; diagnostic kits comprised of medical diagnostic reagents for testing bacteria sensitivity; diagnostic kits comprising medical diagnostic reagents for testing bacteria sensitivity

diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprising diagnostic reagents for testing bacteria sensitivity, except for medical or veterinary use; human, animal, plant and microorganism biological preparations for use in industry and science, namely, for use in drug development; biological preparations for use in industry and science, namely, for treating bacterial contamination in the fields of farming and food preparation; biological preparations for use in industry and science, namely, for treating bacterial contamination in the industrial and food preparation fields

Refrigerators and freezers for medical storage purposes

medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical testing for diagnostic or treatment purposes, namely, providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; medical consulting services in the field of medical diagnostic and prognostic testing; medical services in the nature of medical analysis services for diagnostic and prognostic testing and treatment purposes; medical services in the nature of providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of a person; medical testing and medical diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays

new product research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and pharmaceuticals; medical laboratory services and scientific laboratory services in the nature of clinical and medical laboratory testing services for medical research purposes in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom biochemical assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; biotechnology research; providing medical and scientific research information in the field of clinical trials; new product research and development of vaccines and therapeutics; providing temporary use of online non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections; medical research, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections and the analysis, evaluation and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; laboratory research services in the field of microbiological laboratory testing of bacteria for research purposes and technical consultation relating thereto; scientific and medical research, in particular, design and development of diagnostic assays; medical laboratory services in the nature of testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine; medical laboratory services in the nature of microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 30, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 29, 2023 ABN6
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 4, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 4, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 4, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 4, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 4, 2023 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 25, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 30, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 30, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 10, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 26, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 26, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 26, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 26, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 26, 2022 CNEA
ASSIGNED TO EXAMINER
Jul 20, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2021 NWOS
NEW APPLICATION ENTERED
Nov 8, 2021 NWAP